Park Square has placed Clare Murray, Ph.D. as Chief Executive Officer at EnPlusOne Biosciences.
| less than a minute read
EnPlusOne Biosciences Appoints Clare Murray, Ph.D. as CEO
EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, today announced the appointment of Clare Murray, Ph.D., as Chief Executive Officer.

/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-11-19-15-40-01-479-6aff1851ff5130799d088a3b.png)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-11-06-17-39-37-187-6aee10d9e051d7ffd7756b19.jpeg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-29-16-59-13-899-6abbee61460fb9469a25b973.jpg)